DENVER, Dec. 13, 2012 /PRNewswire/ -- Accelr8
Technology Corporation (NYSE MKT: AXK) announced today the results
of its 2012 Annual Meeting of Shareholders, which was held on
Wednesday, December 12, 2012.
At the Annual Meeting, shareholders re-elected Lawrence Mehren, John
Patience, Jack Schuler and
Matthew Strobeck, Ph.D. as directors
of the Company. Proposals to reincorporate the Company in
Delaware, change the Company's
name to "Accelerate Diagnostics, Inc.", approve a new Certificate
of Incorporation, approve a new Omnibus Equity Incentive Plan, and
ratify the selection of Comiskey & Company, P.C. as the
Company's independent auditors for the upcoming fiscal year were
also approved by shareholders.
The Company plans to file documents with the Delaware and Colorado Secretaries of State to
complete the reincorporation in Delaware and the name change described above
as soon as possible.
For more information about the proposals that were approved by
the Company's shareholders at the Annual Meeting, refer to the
Definitive Proxy Statement that the Company filed with the
Securities and Exchange Commission on November 13, 2012, which is available at
www.sec.gov.
About Accelr8
Accelr8 Technology Corporation is
focused on developing and commercializing innovative
instrumentation for the rapid identification and antibiotic
susceptibility testing of infectious pathogens. The Company's
BACcel™ platform utilizes a proprietary culture-free
process with both genomic and phenotypic detection technologies
that decrease time to result while maintaining high sensitivity and
specificity.
Disclaimer Regarding Forward-Looking
Statements
Certain statements in this news release may be
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Statements
regarding future prospects and developments are based upon current
expectations and involve certain risks and uncertainties that could
cause actual results and developments to differ materially from the
forward-looking statement, including those detailed in the
Company's filings with the SEC. The Company does not
undertake an obligation to publicly update or revise any
forward-looking statements, whether as a result of new information
or future events.
SOURCE Accelr8 Technology Corporation